>>> MaaT Pharma presents Pivotal ARES Phase 3 results for MaaT013 (Xervyteg) in

MaaT Pharma presents Pivotal ARES Phase 3 results for MaaT013 (Xervyteg) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival; Affirms EMA decision on MaaT013 (Xervyteg) expected mid-2026 (update)

  • Presentation included previously disclosed primary results from the pivotal ARES Phase 3 single-arm trial evaluating MaaT013 (Xervyteg) in treating refractory severe acute Graft-versus-Host Disease (aGvHD) patients with gastrointestinal involvement following corticosteroid and ruxolitinib failure.
  • MaaT Pharma announces final pivotal ARES results including a confirmed 1-year overall survival of 54%.
  • Oral presentation and results confirm durable survival benefit in this high-risk patient population known for extremely poor prognosis.
  • MaaT013 (Xervyteg) is currently under regulatory review by the European Medicines Agency (EMA) for Market Approval, with a decision expected mid-2026.

9to5 : Apple TV previews new F1 streaming deal, confirms driver onboard cams wil

Apple TV previews new F1 streaming deal, confirms driver onboard cams will be included

Today was the last race of the 2025 F1 championship, and that also meant the last time ESPN will broadcast a race in the United States. From next year, Apple takes over with all races streaming as part of an Apple TV subscription.

Apple released a new social media ad for the deal today, giving us our first look at how the F1 channel will look inside of the TV app.

As a reminder, Apple announced a five year partnership as the exclusive broadcast partner for F1 in the US, beginning with the 2026 season.

The first race weekend commences on March 6-8, but the service will likely go live in the TV app sooner than that, including some preseason content. All of the Formula 1 content will be available at no extra charge with an Apple TV subscription.

Apple previously said the TV app will incorporate streaming of all practice, qualifying, sprint, and Grand Prix sessions across the season.

From the newly-released screenshots, we can also see that the platform will include streaming onboard driver cams with support for Multiview to show several perspectives at once during a race. (Assuming device compatibility remains the same, Multiview is supported on Apple TV set-top boxes, iPad and Apple Vision Pro.)

Driver onboard cams is one of the features that F1 fans in the US used to need to subscribe to F1.TV to access. Apple has teased that more announcements about “production details” and “product enhancements” will be revealed in the coming months, so you can expect the TV app to add some extra bells and whistles over time.

However, if you are a hardcore fan, you are not limited by the feature set of what Apple makes available directly inside the TV app itself. You will be able to use your Apple TV account to sign into the F1.TV website or the F1.TV apps, and continue to access the sport in the same way as F1.TV subscribers have done so before.

But rather than paying a dedicated subscription just for F1.TV, it is now simply a ‘free’ perk of an Apple TV subscription.

Right now, Apple TV costs $12.99 per month or $99 annually. You can also subscribe to the Apple One bundle and get access to Apple TV at a discounted rate, along with iCloud storage and other Apple content services.

FT : Google’s ‘TPU’ chip puts OpenAI on alert and shakes Nvidia investors

Google’s ‘TPU’ chip puts OpenAI on alert and shakes Nvidia investors
AI advances made through group’s custom processor hits Nvidia’s stock and prompts ChatGPT maker to declare ‘code red’

Google’s secret weapon in the artificial intelligence race is a chip that has helped the search group’s models leap ahead of OpenAI, prompting tech investors to reassess a new threat to Nvidia’s dominance. 

The Big Tech group’s “tensor processing unit” has been central to efforts to boost the performance of Google’s new Gemini 3 AI models, which have outperformed OpenAI’s GPT-5 in independent benchmarking tests.

That development is one factor behind the ChatGPT maker’s “code red” last week, as chief executive Sam Altman told staff to refocus resources into improving its chatbot and models.

Google plans to more than double production of its TPUs by 2028, analysts predict, as it steps up its ambitions for a processor that chip consultancy SemiAnalysis says is now “neck and neck with king of the jungle Nvidia” for building and running cutting-edge AI systems. 

Nvidia investors have also been rattled by the prospect of Google offering TPUs to customers beyond its own cloud computing platform. This includes a recent deal to provide AI start-up Anthropic with 1mn TPUs, worth tens of billions of dollars.

Google argues vertical integration — developing AI hardware, software and chips largely in-house — will deliver both technical advantages and huge profits.

Gemini 3, like Google’s previous models, was trained largely on TPUs. OpenAI relies mainly on Nvidia graphics processing units to build the large language models that power ChatGPT. 


“The most important thing is . . . that full stack approach,” said Koray Kavukcuoglu, Google’s AI architect and DeepMind’s chief technology officer, “I think we have a unique approach there.”

Combining that with understanding how billions of consumers use Gemini, AI overviews in search and other products gives Google a huge advantage, he added. 

Morgan Stanley estimates that every 500,000 TPUs sold to external customers could generate as much as $13bn in revenue for Google. The Big Tech company works primarily with chip design partner Broadcom, as well as with MediaTek, to develop the processors. 

Morgan Stanley analysts also predict that Taiwan Semiconductor Manufacturing Company will produce 3.2mn TPUs next year, growing to 5mn in 2027 and 7mn in 2028.

“Growth in 2027 is significantly stronger than previously anticipated,” the bank’s analysts said in a recent research note.

Nvidia’s stock fell sharply last month following a report in The Information that Meta was in talks with Google to buy TPUs. Meta has declined to comment on the report. 

Some analysts believe Google could also strike such deals with OpenAI, Elon Musk’s xAI or start-ups such as Safe Superintelligence, potentially driving upwards of $100bn in new Google revenues over the coming years. 

Experts add that AI-enabled coding tools could make it easier for potential TPU customers to rewrite their software, which until now has largely been built on top of Nvidia’s proprietary Cuda platform.

Nvidia has sought to assuage market concerns, saying it was still “a generation ahead of the industry” and was “the only platform that runs every AI model”, adding: “We continue to supply to Google.”

The chipmaker added it offers “greater performance, versatility, and fungibility” than processors such as TPUs, “which are designed for specific AI frameworks or functions”.

The origins of Google’s TPU date back to an internal presentation in 2013 by Jeff Dean, Google’s long-serving chief scientist, following a breakthrough in using deep neural networks to improve its speech recognition systems. 

“The first slide was: Good news! Machine learning finally works,” said Jonathan Ross, a Google hardware engineer at the time. “Slide number two said: “Bad news, we can’t afford it.”

Dean calculated that if Google’s hundreds of millions of consumers used voice search for just three minutes a day, the company would have to double its data-centre footprint just to serve that function — at a cost of tens of billions of dollars. 

Ross, who now leads AI chip start-up Groq, said he started working on TPUs in 2013 as a side project as he happened to be sitting next to a team working on Google’s speech recognition technology.

“We built that first chip I think with 15 people,” Ross told a podcast interviewer in December 2023. 

The project has scaled rapidly. One early application was 2016’s famous victory by Google DeepMind’s AlphaGo programme against the world champion of the board game Go, Lee Sedol. The match is considered a significant AI milestone.

The chips have for several years powered many of Google’s core services, including search, advertising and YouTube. 

Google typically releases a new generation of TPU every two years, though that cadence has shifted to annual updates since 2023. 

“Google Cloud is experiencing accelerating demand for both our custom TPUs and Nvidia GPUs,” said a Google spokesperson. “We are committed to supporting both, as we have for years.”

FT : Jay-Z’s investment firm targets $500mn Korean pop culture-focused fund

Jay-Z’s investment firm targets $500mn Korean pop culture-focused fund
MarcyPen Capital Partners bets on K-pop’s global popularity as it agrees partnership with Hanwha Asset Management

Jay-Z’s investment firm is targeting a $500mn fund to back South Korean lifestyle companies as US private equity bets on the global popularity of Korean pop culture.

MarcyPen Capital Partners, which is backed by the rapper, is working with Hanwha Asset Management, the financial arm of one of South Korea’s biggest conglomerates, to raise a private equity fund that will focus on entertainment, beauty, food and lifestyle companies pursuing international growth.

The companies on Tuesday said they had signed an agreement to launch a series of Asian investment funds at the Abu Dhabi Finance Week event.

Korean pop culture has exploded in popularity in recent years, with music groups such as Blackpink and BTS filling arenas around the world and productions such as Squid Game and KPop Demon Hunters dominating streaming platforms.

“There is an opportunity for the global expansion of Korean companies,” said Jong-Ho James Kim, chief executive of Hanwha Asset Management. “Usually Korean companies use their own capital or corporate funds, but if there is third-party assistance, then our growth potential will be greater.”

South Korea’s government has invested billions of dollars into the cultural sector as part of its hallyu, or “Korean wave”, policy to boost the country’s economy and soft power through cultural exports.

The “Korean wave” — which includes industries such as entertainment, beauty, food and fashion — generated more than $31bn globally last year, said Bernie Cho, president of DFSB Kollective, a Korean music export agency. “[It] is now the second-largest consumer goods export out of South Korea” after cars, Cho said.

Kim said private equity had not previously funded Korean culture, entertainment and sports ventures aiming for global expansion. 

Hanwha will source the companies, Kim said, while MarcyPen has “a good track record in operating funds for lifestyle, fashion and food” and the ability to identify high-potential targets.

Hanwha Asset Management is part of Hanwha Group, which also owns South Korea’s largest defence contractor. The money manager has more than Won122tn ($83bn) in assets under management.

MarcyPen was formed in 2024 by the merger of Marcy Capital Partners, which was co-founded by Jay-Z, and the investment arm of Pendulum Holdings.

The company “provides strategic capital to growth-stage consumer businesses that create, move and lead culture”, according to its website. It manages $1.1bn in assets. Past investments include minimalist cosmetics maker Merit Beauty and Rael, an organic feminine care brand.

“South Korea is a cultural nexus of Asia, influencing global trends in beauty, content, food, entertainment and lifestyle, making it the ideal gateway for our partnership with Hanwha,” Robbie Robinson, managing partner and chief executive of MarcyPen, said in a statement.

The fund aims to begin raising money in the second half of next year from institutional investors, sovereign wealth funds and wealthy individuals.

FT : La Scala season opens with Shostakovich’s visceral Lady Macbeth of Mtsensk

La Scala season opens with Shostakovich’s visceral Lady Macbeth of Mtsensk
Conducting his last opening night as music director, Riccardo Chailly gave listeners a performance to remember

As a centrepiece of the ongoing Shostakovich anniversary, the choice of opera was as audacious as it was obvious. Lady Macbeth of Mtsensk — the Russian composer’s towering 1934 work with graphic adultery, multiple murders and an orchestral score that leaves little to the imagination — fell foul of the Soviet censors and was dismissed as “pornography”. Yet here it was on the opening night of La Scala’s season, a high-stakes highlight of the Italian cultural calendar attended by the political elite and beamed to millions of television viewers nationwide.

The subject matter is hardly light entertainment. Katerina, a lonely merchant’s wife in rural 19th-century Russia, makes off with the newly employed workman, Sergei, before poisoning her father-in-law, Boris, and strangling her husband, Zinovy, whose corpse she hides in the cellar. Days after Stalin stormed out of a 1936 performance, Pravda denounced the work as “muddle instead of music”. Now, 50 years since Shostakovich’s death, one might have imagined similarly scandalised audience members — at an event often more memorable for offstage pageantry (police in plumed hats, paparazzi crushes and celebrities brandishing tickets worth €3,200) than the opera production itself.

Not this year. Director Vasily Barkhatov, the Russian director making his house debut, updates the action to a restaurant during the dying days of Stalinism, dividing the action between a monumental dining hall and a seedy back of house with an upper kitchen and a cellar below. By way of an effective flashback device, suspects and witnesses relive unspeakable crimes during police interrogations, giving events a grim inevitability. While families watching on TV are spared onstage sex, the fully clothed Katerina and Sergei re-enact the scene as officers take photos and Shostakovich’s score pants and grunts. The result is doubly disturbing.

Barkhatov showcases mastery of detail, weaving black humour — restaurant staff bungling a dead body through a jammed door, or blithely sweeping a floor as their poisoned employer writhes — with imagery so sleazy you are left wanting a shower. A gang of chefs overpower the workwoman Aksinya in the kitchen while a priest downs vodka in the cellar. When a creeping Zinovy secretly catches Katerina and Sergei in the act, the subsequent intermezzo preceding their apparent discovery sounds especially sinister.

Conducting his last opening night as music director after nearly a decade in the role, Riccardo Chailly gave listeners a performance to remember. He sands down Shostakovich’s rough edges — La Scala’s luminous strings at times have a Mahlerian quality — while suffusing gorgeously sculpted interludes with aching despair and black doom. At times, playing was astonishingly intense. Lined up on the restaurant’s mezzanine to salute Boris’s coffin below, brass players unleashed a wave of visceral rage that stays with you long after the performance. The excellent chorus gave similarly powerful deliveries. 

With his inky voice and domineering presence, Alexander Roslavets’s ferocious Boris conjured much of the performance’s brutality. Yevgeny Akimov’s fluttering tenor made for a comically dithering Zinovy. Najmiddin Mavlyanov’s strapping Sergei was equally believable as seducer and swindler. As Katerina, Sara Jakubiak had little trouble standing out from the coterie of despicable males, keeping listeners gripped right until her shocking final self-immolation in place of the libretto’s river drowning. 

FT : Hedge fund ordered to pay bonus to trader who made 97% of its revenues

Hedge fund ordered to pay bonus to trader who made 97% of its revenues
Evolution Capital Management must pay Robert Gagliardi $5.4mn plus interest after High Court judgment

A hedge fund that was sued by a trader for refusing to pay a performance-related bonus, despite him making 97 per cent of its revenue, has been ordered to pay him $5.4mn plus interest by the High Court in London.

Robert Gagliardi sued his former employer, Evolution Capital Management, in London, alleging that it acted in bad faith by denying him a $7.5mn discretionary bonus after he had generated more than $60mn for the firm between April 2021 and March 2022.

The bonus will bring Gagliardi’s total pay for his brief stint at the fund to more than $12mn. He was already paid $7mn by Evolution, including a $625,000 signing bonus, a base salary of about $425,000 and a $6mn “new issue bonus” for successfully trading initial public offerings.

Gagliardi, a block trading specialist nicknamed “Gags”, alleged that he was told in early 2021 that a return of $10mn over the rest of the year would be an “excellent result”. When Gagliardi asked the fund’s founder Michael Lerch for the payout in 2022, he responded: “I’m not going to pay you the bonus, fnck you, sue me.”

Although Evolution did not dispute his extraordinary returns, the fund argued that the damage done to its reputation as a result of dealing with a US Securities and Exchange Commission probe into some of Gagliardi’s trades at his previous employer outweighed his performance, and that the bonus did not need to be paid because it was discretionary.

“There is no question that Mr Gagliardi made exceptional profit for the funds and Mr Lerch frequently praised his performance in that respect,” Mr Justice Calver said in his judgment. “Had [Evolution] properly performed the contract, Mr Gagliardi would have received a discretionary bonus of US$5,385,000.” The judge also said that Gagliardi was Lerch’s “prize asset” at Evolution.

Seth Redniss, Gagliardi’s lawyer, called the ruling a “decisive vindication”.

The trades of the former Segantii Capital Management employee came under scrutiny during a wide-ranging US probe into Morgan Stanley that coincided with his employment at Evolution. During the investigation, Gagliardi had his phone confiscated by US officials and frequently fell out with colleagues, the High Court was told. 

The hedge fund said the fact that Gagliardi’s trades had been scrutinised in the investigation that led to the Wall Street bank paying $249mn to settle last year was a factor in its decision not to pay the bonus. In particular, it pointed to his relationship to the former head of Morgan Stanley’s US equity syndicate, Pawan Passi.

In its original filing, Evolution — which countersued Gagliardi for the $7mn it paid him while working there — said the “inappropriate” relationship between the two amounted to a breach of trust.

The hedge fund gave him notice that it was terminating his contract in late February 2022. Gagliardi reiterated throughout the trial that he had been cleared of any wrongdoing by the SEC.

While Gagliardi faced intensive questioning in court over whether he had deliberately lost a mobile phone, the judge wrote in his judgment that he did not consider the trader’s evidence to be “dishonestly given”, adding that he remained “impressively calm” throughout his testimony.

Gagliardi also told the court that the subpoena he was served while employed by Evolution also listed some of “the biggest names” in equity capital markets, and that he “would have probably been insulted” if not included in the document.

Scrutinising his trading history, Paul Downes KC, representing Evolution, referenced several news stories, one of which described Gagliardi’s trading activity as being conducted in a “grey area”. Gagliardi dismissed their relevance, stating that “these are just journalists” and their job involved oversimplifications “like when I explain it to my mum in Queens”.

In its original filings and throughout the trial, Evolution described Gagliardi as an “abrasive” employee who breached risk limits on several occasions. Evolution argued that this was another reason it was able to deny his bonus, although it did not dismiss him at the time of the alleged offences.

In written arguments prepared for the High Court trial that concluded in October, Gagliardi’s lawyers said that, following several disagreements, he asked Lerch if he could be made co-chief investment officer in September 2021.

When his request was denied, Zoltan Varga, a former executive at hedge fund Och-Ziff Capital Management and “a key investor” in Evolution, asked Lerch whether he could offer Gagliardi another title. Lerch proposed his own title for Gagliardi: “Fnck face”.

Gagliardi also claimed that a month later, when Lerch was discussing with colleagues the possibility of the equity capital markets trader leaving Evolution, he commented that if he did, he “would learn the meaning of discretionary very fast”, referring to the disputed discretionary bonus.

Alongside Morgan Stanley’s settlement with the SEC, Passi admitted to misconduct for leaking confidential information to investors and was issued a $250,000 penalty. The authorities did not name or announce any actions against recipients of the information.

Evolution did not immediately respond to a request for comment.

>>> US Research Calls I

Research Calls I
  • Upgrades
    • Allison Transmission (ALSN) upgraded to Strong Buy from Outperform at Raymond James, tgt $110
    • Bayer (BAYRY) upgraded to Overweight from Neutral at JPMorgan
    • Cemex (CX) upgraded to Sector Perform from Underperform at RBC Capital, tgt $11.25
    • Canadian Pacific (CP) upgraded to Overweight from Equal Weight at Morgan Stanley
    • CNX Resources (CNX) upgraded to Neutral from Underweight at JPMorgan, tgt $38
    • Compass (COMP) upgraded to Overweight from Equal Weight at Barclays, tgt $13
    • Devon Energy (DVN) upgraded to Overweight from Neutral at JPMorgan, tgt $44
    • Equity Lifestyle (ELS) upgraded to Outperform from Sector Perform at RBC Capital, tgt $70
    • Exxon Mobil (XOM) upgraded to Neutral from Underperform at BNP Paribas Exane, tgt $114
    • Five Below (FIVE) upgraded to Buy from Hold at Truist, tgt $216
    • Generac (GNRC) upgraded to Overweight from Neutral at JPMorgan, tgt $200
    • General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $90
    • Incyte (INCY) upgraded to Outperform from Neutral at Mizuho, tgt $121
    • Inspire Medical (INSP) upgraded to Outperform from Perform at Oppenheimer, tgt $175
    • Jack Henry (JKHY) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $215
    • Jefferies Financial (JEF) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $78
    • KB Home (KBH) upgraded to Overweight from Equal Weight at Barclays, tgt $71
    • MasterCard (MA) upgraded to Buy from Hold at HSBC, tgt $633
    • Novartis (NVS) upgraded to Overweight from Neutral at JPMorgan
    • Old Dominion (ODFL) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $190
    • Oklo (OKLO) upgraded to Buy from Neutral at Seaport Research, tgt $150
    • Quanta Services (PWR) upgraded to Overweight from Neutral at JPMorgan, tgt $515
    • Ralliant (RAL) upgraded to Buy from Neutral at Citigroup, tgt $61
    • Roche (RHHBY) upgraded to Neutral from Underweight at JPMorgan
    • SiteOne Landscape (SITE) upgraded to Equal Weight from Underweight at Barclays, tgt $134
    • Synopsys (SNPS) upgraded to Neutral from Underperform at BofA Securities, tgt $500
    • Champion Homes (SKY) upgraded to Overweight from Equal Weight at Barclays, tgt $100
    • Thermo Fisher (TMO) upgraded to Overweight from Sector Weight at KeyBanc, tgt $750
    • Ulta Beauty (ULTA) upgraded to Buy from Hold at TD Cowen, tgt $725
    • Visa (V) upgraded to Buy from Hold at HSBC, tgt $389
    • Vodafone (VOD) upgraded to Overweight from Equal Weight at Barclays
  • Downgrades
    • 3M (MMM) downgraded to Hold from Buy at Deutsche Bank, tgt $178
    • Amrize (AMRZ) downgraded to Sector Perform from Outperform at RBC Capital, tgt $60
    • Antero Resources (AR) downgraded to Neutral from Overweight at JPMorgan, tgt $39
    • Enlight Renewable (ENLT) downgraded to Underweight from Neutral at JPMorgan, tgt $35
    • Ero Copper (ERO) downgraded to Hold from Buy at Jefferies
    • Evercore (EVR) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $373
    • Ferrari (RACE) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $425
    • Fluence Energy (FLNC) downgraded to Underperform from Neutral at Mizuho, tgt $15
    • Knot Offshore Partners (KNOP) downgraded to Neutral from Buy at Alliance Global
    • Lennar (LEN) downgraded to Underweight from Equal Weight at Barclays, tgt $98
    • Lucid Group (LCID) downgraded to Underweight from Equal Weight at Morgan Stanley, tgt $10
    • Marvell (MRVL) downgraded to Hold from Buy at Benchmark
    • Masco (MAS) downgraded to Equal Weight from Overweight at Barclays, tgt $71
    • Netflix (NFLX) downgraded to Hold from Buy at Pivotal Research, tgt $105
    • Novo Nordisk (NVO) downgraded to Hold from Buy at Argus
    • Occidental (OXY) downgraded to Underweight from Neutral at JPMorgan, tgt $44
    • PBF Energy (PBF) downgraded to Underperform from Peer Perform at Wolfe Research, tgt $23
    • Peoples Financial (PFIS) downgraded to Equal Weight from Overweight at Stephens, tgt $50
    • Primoris (PRIM) downgraded to Neutral from Overweight at JPMorgan, tgt $143
    • Procept BioRobotics (PRCT) downgraded to Neutral from Buy at BofA Securities, tgt $38
    • Range Resources (RRC) downgraded to Underweight from Neutral at JPMorgan, tgt $39
    • Rivian (RIVN) downgraded to Underweight from Equal Weight at Morgan Stanley, tgt $12
    • Sanofi (SNY) downgraded to Neutral from Overweight at JPMorgan
    • Tesla (TSLA) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $425
    • W.P. Carey (WPC) downgraded to Sector Perform from Outperform at RBC Capital, tgt $69
  • Others
    • Aveanna Healthcare (AVAH) initiated with an Outperform at William Blair
    • Blue Owl Technology Finance (OTF) initiated with an Outperform at Citizens JMP, tgt $17
    • BrightSpring Health (BTSG) initiated with an Outperform at William Blair
    • Canaan (CAN) initiated with a Buy at BTIG Research, tgt $3
    • Carlyle Secured Lending (CGBD) initiated with a Market Perform at Citizens JMP
    • Capital One (COF) assumed with an Outperform at Wolfe Research, tgt $270
    • Commvault (CVLT) initiated with an Outperform at Mizuho, tgt $190
    • Customers Bancorp (CUBI) initiated with an Equal Weight at Morgan Stanley, tgt $90
    • HeartBeam (BEAT) initiated with a Buy at H.C. Wainwright, tgt $2.50
    • Integra Resources (ITRG) initiated with a Buy at Roth Capital, tgt $5.75
    • Main Street Capital (MAIN) initiated with an Outperform at Citizens JMP, tgt $70
    • Matador Resources (MTDR) initiated with a Buy at Citigroup, tgt $53
    • LP Building Solutions (LPX) initiated with an Overweight at Barclays, tgt $100
    • Pasithea Therapeutics (KTTA) initiated with a Buy at H.C. Wainwright, tgt $3
    • Okyo Pharma (OKYO) initiated with a Buy at B. Riley, tgt $5
    • OneMain (OMF) initiated with a Buy at Truist, tgt $75
    • Pennant Group (PNTG) initiated with an Outperform at William Blair
    • Pinnacle Financial (PNFP) initiated with a Buy at BofA Securities, tgt $113
    • SanDisk (SNDK) initiated with a Neutral at JPMorgan, tgt $235
    • South Bow (SOBO) initiated with an Equal Weight at Barclays, tgt $27
    • Trinity Capital (TRIN) initiated with an Outperform at Citizens JMP, tgt $17.50

The Information : How Archer Aviation Has Ceded the Lead to Air Taxi Rival Joby

How Archer Aviation Has Ceded the Lead to Air Taxi Rival Joby Aviation

Archer Aviation has been on a roll. It has cut electric air taxi deals in Japan and with Florida billionaire investor Stephen Ross. Last month, it received its first revenue from Abu Dhabi as part of plans to begin commercial air taxi flights next year there, too.

There’s a tiny hitch: Archer’s proposed commercial aircraft, called Midnight, has never been on a piloted flight. The San Jose, Calif., startup has repeatedly canceled piloted public demonstrations of the aircraft, most recently last month at the Dubai Airshow, where its main rival, Joby Aviation, conducted piloted public flights on five consecutive days.

Archer says it’s on track to begin commercial flights next year in the United Arab Emirates, in at least one U.S. city, or both. And last month it opened a potential new line of revenue as an equipment supplier to defense contractors, signing a deal to provide electric motors for a hybrid autonomous drone under co-development by Anduril Industries and the Emirates-based Edge Group.

In the Japan deal, Archer can sell up to 100 Midnights to a joint venture of Japan Airlines and Sumitomo as soon as regulators certify the aircraft, with plans to fly short hops in Tokyo, Osaka and three other destinations in the country. Ross plans to partner with Archer to build multiple air taxi facilities, called vertiports, as soon as next year connecting south Florida airports and other locations with his West Palm Beach office and residential properties.

But reported bugs in Midnight, affecting its rear propellers, and the cancellation of three booked exhibitions of the aircraft over the last year have created doubts about Archer’s ability to deliver the aircraft it has promised next year.

“Archer’s very good at making deals,” said Gary Vermaak, chief of staff at the Advanced Air Mobility Institute, a South Africa–based think tank that studies electric aviation. “What the deals are worth or are going to be worth is questionable.”

In an interview, Eric Lentell, Archer’s chief strategy officer, said he expects Midnight to fly in the second half of next year under a Trump administration program allowing commercial electric air taxis to operate even if they lack full regulatory approval. He said the company had simply changed its mind about participating in the air shows.

The company declines to comment on whether it’s had trouble getting its new rear propellers—a four-blade configuration—to work properly. Lentell told me the company hadn’t yet flown the new Midnight configured with the four-blade propeller but would fly a piloted version of it in the next few months.

Wall Street has pushed Joby’s share price up 89% year to date while pushing down Archer’s 10%. But Archer, founded in 2018, has had no problems raising money: It has raised $1.8 billion in three rounds this year alone, two involving equity and one debt, and it ended the third quarter with $1.6 billion in cash, cash equivalents and short-term investments. Its market cap is $5.7 billion.

The two companies are in stiff competition to hold the attention of investors and regulators: Each has raised and spent billions of dollars to develop their aircraft, and both will need tens of billions more to build and scale manufacturing plants aiming to turn out hundreds and eventually thousands of the vehicles.

They are both now also aiming for military sales, meaning they need to capture and keep the attention of defense officials around the world as well.

Their rivalry has created some bad blood: Last month, Joby sued Archer, claiming it stole trade secrets by hiring away a Joby employee it said took with him confidential information about its business strategy. Archer has denied the allegations.

Industry veterans generally treat Archer and Joby as more or less technological equals, but it’s not clear why that is the case given that Joby appears to have an edge. In April, for instance, Joby’s prototype commercial vehicle was first to carry out a difficult maneuver—lifting off vertically like a helicopter and then zooming ahead horizontally like a plane, the capability that sets such aircraft apart from helicopters. The maneuver, with a pilot aboard, is treated as the ultimate proving ground for who in the field is serious and who isn’t.

Joby carried out that maneuver multiple times at the Dubai Airshow. Archer said it also conducted a transition flight the previous week in Abu Dhabi. But from the standpoint of street cred, its exhibition had at least two strikes against it: It was an unpiloted aircraft, considered inherently less risky because no one’s life was on the line, and it was an early version of Midnight, not the one intended for regulatory certification.

Archer’s decision to back out of flights at air shows in South Korea, Japan and Dubai over the last year has attracted industry attention. Archer says it simply decided to devote its time where it most counts—in Abu Dhabi, where it seems likely to deploy its first commercial aircraft next year; and in Salinas, Calif., where it’s developing the Midnight.

But that approach contrasts sharply with the startup’s otherwise bold marketing style: It has spent tens of millions of dollars to be the official air taxi provider and a sponsor of both the 2026 World Cup and the 2028 Olympics. The Olympics and some World Cup games will take place in Los Angeles, and Archer spent $126 million alone to buy Hawthorne Airport, near the southern California city, for use during the events.

Nikhil Goel, Archer’s chief commercial officer, told me the company plans to turn the airport into “the AI-powered airport of the future,” with AI used in passenger identification, in air traffic control and for security.

Archer is relying on the Trump administration’s program to get off the ground next year. Lentell said Archer would apply with the Department of Transportation to operate Midnight in Huntington Beach, Calif. If the agency approves the application, Huntington Beach could serve as a jumping-off point for Archer’s operations around the World Cup and the Olympics, Lentell said.

Part of the reason for Archer’s slower deployment is a change it made this year to the Midnight’s design, altering it from a two-blade propeller to a four-blade version. For aerodynamic reasons, the propellers are supposed to stow alongside the fuselage, according to The Air Current, a publication on electric aviation. But Archer has not yet flown this new version.

Lentell did not dispute that Joby’s aircraft is technologically ahead of Archer’s but said Archer is strategically going after a different objective: It is developing an aircraft that can take off, land and fly both like a plane and a helicopter; Joby’s aircraft is designed to fly only like a helicopter.

Archer, too, wants its aircraft to eventually fly exclusively like a helicopter, he said, but current airports aren’t widely configured for such aircraft. “We think it’'s going to be really important to be able to operate in and out of as much infrastructure as possible that already exists,” Lentell said.

>>> US Gapping down

Gapping down
News:
  • CRWV -6.7% (to offer $2 billion aggregate principal amount of its convertible senior notes due 2031 in a private offering)
  • GROY -5.6% (announces $70.0 million bought deal financing)
  • ITT -4.9% (to offer $2 billion aggregate principal amount of its convertible senior notes due 2031 in a private offering)
  • MATW -2.8% (outlines shareholder value actions, addresses director nominations)
  • AVX -2.6% (files $2 bln mixed securities shelf offering)
  • WS -2.1% (confirms merge negotiations for Klöckner & Co SE)
  • IDYA -1.7% (discloses in filing that GlaxoSmithKline Intellectual Property communicated to company its intention to terminate the collaboration, option, and license agreement dated June 15, 2020)
  • TSLA -1.3% (Dept of Transportation letter to Tesla; A leaked video shows Optimus robot falling, according to Giz Mo China)
  • GNK -1% (provides updated Q4 estimated TCE update)
  • AGIO -1% (provides update on U.S. sNDA for mitapivat in thalassemia)

>>> US Gapping up

Gapping up
Select pharma/biotech stocks trading higher following ASH/presentations:
  • FULC +45.6%, NRIX +16.9%, ACLX +15.1%, ALXO +9.9%, DYN +8.1%, SLS +7.2%, WVE +6%, PRME +5.3%, ORIC +4.5%, AAPG +4.4%, SNDX +3.3%, BNTX +3%, EVAX +2.9%, BEAM +1.9%, INCY +1.7%, ADPT +1.5%, GMAB +0.9%
Other news:
  • IMMX +19.6% (reports Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis; prices upsized $100 mln underwritten offering)
  • KYMR +17.3% (to announce KT-621 BroADen Phase 1b Atopic dermatitis trial results on December 8 )
  • OCUL +13.6% (plans accelerated NDA for AXPAXLI in wet AMD; intends to submit a new drug application for its product candidate AXPAXLI)
  • BIDU +3.1% (confirms it is in the process of assessing proposed spin-off and listing)
  • LYEL +3% (Presents New Clinical Data from Ongoing Trial of Ronde-Cel; files for 1.9 mln share common stock offering by selling shareholder)
  • SNN +1.9% (unveils RISE strategy and sets 2028 financial targets)
  • GLSI +1.8% (announces completion of enrollment in the open label arm of FLAMINGO-01)
  • HOOD +1.7% (entered into agreements to acquire Indonesian brokerage PT Buana Capital Sekuritas and licensed digital asset trader PT Pedagang Aset Kripto)
  • OBIO +1.6% (announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting)
  • RZLT +1.4% (files mixed securities shelf offering)
  • FRMI +1.1% (signs a definitive Electric Service Agreement with Southwestern Public Service Company; executes electric service agreement with Xcel Energy subsidiary for Project Matador)